Multi-drug-resistant tuberculosis (patient information): Difference between revisions
Joao Silva (talk | contribs) No edit summary |
Joao Silva (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{JS}} | {{CMG}}; {{AE}} {{JS}} | ||
==Overview== | ==Overview== | ||
Anti-tuberculosis ([[TB]]) drug resistance is a major [[public health]] problem that threatens progress made in [[TB]] care and control worldwide. [[Drug resistance]] arises due to improper use of [[antibiotics]] in chemotherapy of drug-susceptible TB patients. This improper use is a result of a number of actions including, administration of improper treatment regimens and failure to ensure that patients complete the whole course of treatment. Essentially, [[drug resistance]] arises in areas with weak [[TB]] control programmes.<ref name=WHO>{{cite web | title = Multidrug-resistant tuberculosis | url = http://www.who.int/tb/challenges/mdr/en/ }}</ref> | |||
[[Multidrug-resistant TB]] ([[MDR-TB]]) is caused by [[Mycobacterium tuberculosis]] that is [[Drug resistance|resistant]] to at least [[isoniazid]] and [[rifampin]], the two most potent [[TB]] drugs. These drugs are used to treat all persons with [[TB]] disease.<ref name=CDC>{{cite web | title = Tuberculosis Fact Sheet | url = http://www.cdc.gov/tb/publications/factsheets/drtb/mdrtb.htm }}</ref> | [[Multidrug-resistant TB]] ([[MDR-TB]]) is caused by [[Mycobacterium tuberculosis]] that is [[Drug resistance|resistant]] to at least [[isoniazid]] and [[rifampin]], the two most potent [[TB]] drugs. These drugs are used to treat all persons with [[TB]] disease.<ref name=CDC>{{cite web | title = Tuberculosis Fact Sheet | url = http://www.cdc.gov/tb/publications/factsheets/drtb/mdrtb.htm }}</ref> | ||
==What are the symptoms of Multi-drug-resistant tuberculosis?== | ==What are the symptoms of Multi-drug-resistant tuberculosis?== | ||
Revision as of 13:19, 21 July 2014
For the WikiDoc page for this topic, click here
|
Multi-drug-resistant tuberculosis |
|
Where to find medical care for Multi-drug-resistant tuberculosis? |
|---|
|
Multi-drug-resistant tuberculosis On the Web |
|
Directions to Hospitals Treating Multi-drug-resistant tuberculosis |
|
Risk calculators and risk factors for Multi-drug-resistant tuberculosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Anti-tuberculosis (TB) drug resistance is a major public health problem that threatens progress made in TB care and control worldwide. Drug resistance arises due to improper use of antibiotics in chemotherapy of drug-susceptible TB patients. This improper use is a result of a number of actions including, administration of improper treatment regimens and failure to ensure that patients complete the whole course of treatment. Essentially, drug resistance arises in areas with weak TB control programmes.[1]
Multidrug-resistant TB (MDR-TB) is caused by Mycobacterium tuberculosis that is resistant to at least isoniazid and rifampin, the two most potent TB drugs. These drugs are used to treat all persons with TB disease.[2]
What are the symptoms of Multi-drug-resistant tuberculosis?
What causes Multi-drug-resistant tuberculosis?
The causes of multi-drug resistance to anti-TB drugs can occur when drugs are misused or mismanaged:[2]
- When patients do not complete their full course of treatment
- When health-care providers prescribe the wrong treatment, the wrong dose, or length of time for taking the drugs
- When the supply of drugs is not always available
- When the drugs are of poor quality